Skip to main content

Table 4 Primary measures

From: An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)

Outcome domain

Measure

Definition

Tolerability

Adherence to a regimen of LSD microdoses

Percentage of participants who withdraw from the trial due to adverse events related to the treatment regimen

Feasibility

Compliance with LSDDEP1 study procedures to determine the feasibility of conducting LSDDEP2

Percentage of attended clinic visits once enrolled

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784